| 1 |
Vijayaraghavan R, Sarin SK, Bharadwaj A, Anand L, Maiwall R, Choudhury A, Benjamin J, Kanal U, Jamwal KD. Intragastric Balloon in Obese Compensated Nonalcoholic Steatohepatitis Cirrhosis Patients Is Safe and Achieves Significant Weight Reduction at 6-Months. Dig Dis Sci 2023;68:1035-41. [PMID: 35763235 DOI: 10.1007/s10620-022-07596-4] [Reference Citation Analysis]
|
| 2 |
Battistella S, D'Arcangelo F, Grasso M, Zanetto A, Gambato M, Germani G, Senzolo M, Russo FP, Burra P. Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management. Clin Mol Hepatol 2023;29:S286-301. [PMID: 36577425 DOI: 10.3350/cmh.2022.0392] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Villeret F, Dharancy S, Erard D, Abergel A, Barbier L, Besch C, Boillot O, Boudjema K, Coilly A, Conti F, Corpechot C, Duvoux C, Faitot F, Faure S, Francoz C, Giostra E, Gugenheim J, Hardwigsen J, Hilleret MN, Hiriart JB, Houssel-Debry P, Kamar N, Lassailly G, Latournerie M, Pageaux GP, Samuel D, Vanlemmens C, Saliba F, Dumortier J. Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis. JHEP Rep 2023;5:100668. [PMID: 36852108 DOI: 10.1016/j.jhepr.2022.100668] [Reference Citation Analysis]
|
| 4 |
Juárez-Hernández E, Velázquez-Alemán AP, Castro-Narro G, Uribe M, López-Méndez I. Bariatric endoscopic-surgical therapies for NAFLD. Should they be considered viable options among current treatments? Front Endocrinol (Lausanne) 2022;13:1026444. [PMID: 36523596 DOI: 10.3389/fendo.2022.1026444] [Reference Citation Analysis]
|
| 5 |
Mandour MO, El-Hassan M, Elkomi RM, Oben JA. Non-alcoholic fatty liver disease: Is surgery the best current option and can novel endoscopy play a role in the future? World J Hepatol 2022;14:1704-17. [PMID: 36185721 DOI: 10.4254/wjh.v14.i9.1704] [Reference Citation Analysis]
|
| 6 |
Nakatsuka T, Tateishi R, Koike K. Changing clinical management of NAFLD in Asia. Liver Int 2022;42:1955-68. [PMID: 34459096 DOI: 10.1111/liv.15046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 7 |
Huh G, Kwon J, Kim SH, Lim HJ, Min SH, Park DH. Effect of Novel Gastro-Duodenal Flow Restrictor on Relative Weight Loss and Glucose Levels in a Porcine Model: A Pilot Randomized Study. Nutrients 2022;14:2563. [DOI: 10.3390/nu14132563] [Reference Citation Analysis]
|
| 8 |
Galasso G, D’alessandro A, Giardiello C. Endoscopic Sleeve Gastroplasty. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy 2022. [DOI: 10.1007/978-3-030-56993-8_44] [Reference Citation Analysis]
|
| 9 |
Villeret F, Dumortier J, Erard-Poinsot D. How will NAFLD change the liver transplant landscape in the 2020s? Clin Res Hepatol Gastroenterol 2022;46:101759. [PMID: 34311133 DOI: 10.1016/j.clinre.2021.101759] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Han MAT, Olivo R, Choi CJ, Pyrsopoulos N. De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation. World J Hepatol 2021;13:1991-2004. [PMID: 35070003 DOI: 10.4254/wjh.v13.i12.1991] [Reference Citation Analysis]
|
| 11 |
Jagtap N, Kalapala R, Katakwar A, Sharma M, Aslam M, Gupta R, Rao PN, Goud R, Tandan M, Kanakagiri H, Darishetty S, Reddy DN. Endoscopic sleeve gastroplasty - minimally invasive treatment for non-alcoholic fatty liver disease and obesity. Indian J Gastroenterol 2021;40:572-9. [PMID: 34914039 DOI: 10.1007/s12664-021-01202-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 12 |
Mendoza YP, Becchetti C, Watt KD, Berzigotti A. Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases. Semin Liver Dis 2021;41:448-60. [PMID: 34243194 DOI: 10.1055/s-0041-1731705] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 13 |
Salomone F, Currenti W, Magrì G, Boškoski I, Zelber-Sagi S, Galvano F. Effects of intragastric balloon in patients with nonalcoholic fatty liver disease and advanced fibrosis. Liver Int 2021;41:2112-6. [PMID: 33938630 DOI: 10.1111/liv.14917] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 14 |
Brunaldi VO, Galvao Neto M. Primary Endoscopic Treatments for Obesity. Curr Surg Rep 2021;9. [DOI: 10.1007/s40137-021-00291-9] [Reference Citation Analysis]
|
| 15 |
Xanthakos SA. Pharmacological, Endoscopic, Metabolic, and Surgical Procedures for Nonalcoholic Fatty Liver Disease. Clin Liver Dis (Hoboken) 2021;17:209-14. [PMID: 33868667 DOI: 10.1002/cld.1030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 16 |
Zou ZY, Zeng J, Ren TY, Shi YW, Yang RX, Fan JG. Efficacy of Intragastric Balloons in the Markers of Metabolic Dysfunction-associated Fatty Liver Disease: Results from Meta-analyses. J Clin Transl Hepatol 2021;9:353-63. [PMID: 34221921 DOI: 10.14218/JCTH.2020.00183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 17 |
Patton H, Heimbach J, McCullough A. AGA Clinical Practice Update on Bariatric Surgery in Cirrhosis: Expert Review. Clin Gastroenterol Hepatol 2021;19:436-45. [PMID: 33393473 DOI: 10.1016/j.cgh.2020.10.034] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 18 |
Silva LB, Neto MG. Intragastric balloon. Minim Invasive Ther Allied Technol 2021;:1-10. [PMID: 33571068 DOI: 10.1080/13645706.2021.1874420] [Reference Citation Analysis]
|
| 19 |
Hernández-Aguilera A, Casacuberta N, Castañé H, Fibla M, Fernández-Arroyo S, Fort-Gallifa I, París M, Sabench F, Del Castillo D, Baiges-Gaya G, Rodríguez-Tomàs E, Sans T, Camps J, Joven J. Nonalcoholic Steatohepatitis Modifies Serum Iron-Related Variables in Patients with Morbid Obesity. Biol Trace Elem Res 2021. [PMID: 33559024 DOI: 10.1007/s12011-021-02610-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 20 |
Petroni ML, Brodosi L, Bugianesi E, Marchesini G. Management of non-alcoholic fatty liver disease. BMJ 2021;372:m4747. [PMID: 33461969 DOI: 10.1136/bmj.m4747] [Cited by in Crossref: 59] [Cited by in F6Publishing: 47] [Article Influence: 29.5] [Reference Citation Analysis]
|
| 21 |
Galasso G, D’alessandro A, Giardiello C. Endoscopic Sleeve Gastroplasty. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy 2021. [DOI: 10.1007/978-3-030-29964-4_44-1] [Reference Citation Analysis]
|
| 22 |
Burra P, Becchetti C, Germani G. NAFLD and liver transplantation: Disease burden, current management and future challenges. JHEP Rep 2020;2:100192. [PMID: 33163950 DOI: 10.1016/j.jhepr.2020.100192] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 14.3] [Reference Citation Analysis]
|
| 23 |
Lanthier N. Les nouveaux traitements de la stéatohépatite non-alcoolique. Nutrition Clinique et Métabolisme 2020;34:216-22. [DOI: 10.1016/j.nupar.2020.04.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
